切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2021, Vol. 15 ›› Issue (02) : 150 -153. doi: 10.3877/cma.j.issn.1674-3946.2021.02.010

所属专题: 文献

论著

改良Devine术在晚期不可切除远端胃癌中应用效果评价
王伟1, 马成民2, 汤东1, 汪刘华1, 孟庆洋1, 王道荣1,()   
  1. 1. 225001 江苏省苏北人民医院,扬州大学临床医学院,扬州大学-扬州市普通外科研究所
    2. 116044 大连医科大学扬州临床医学院
  • 收稿日期:2020-06-19 出版日期:2021-04-26
  • 通信作者: 王道荣

Clinical evaluation of Modified Devine exclusion for patients with unresectable distal gastric cancer

Wei Wang1, Chengmin Ma2, Dong Tang1, Liuhua Wang1, Qingyang Meng1, Daorong Wang1,()   

  1. 1. YangZhou University-Yangzhou Institute of General Surgery, Subei People's Hospital of Jiangsu province, Yangzhou University Clinical Medical College, Jiangsu 225001, China
    2. Yangzhou Clinical Medical College of Dalian Medical University, Liaoning 116044 , China
  • Received:2020-06-19 Published:2021-04-26
  • Corresponding author: Daorong Wang
  • Supported by:
    National Natural Science Foundation of China(81871317)
引用本文:

王伟, 马成民, 汤东, 汪刘华, 孟庆洋, 王道荣. 改良Devine术在晚期不可切除远端胃癌中应用效果评价[J/OL]. 中华普外科手术学杂志(电子版), 2021, 15(02): 150-153.

Wei Wang, Chengmin Ma, Dong Tang, Liuhua Wang, Qingyang Meng, Daorong Wang. Clinical evaluation of Modified Devine exclusion for patients with unresectable distal gastric cancer[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2021, 15(02): 150-153.

目的

探讨不同两种术式应用晚期不可切除远端胃癌患者的安全性及可行性。

方法

回顾性分析2012年9月至2019年9月期间行手术治疗的61例晚期远端不可切除胃癌患者的临床资料。其中25例行改良Devine术(改良组),36例行传统胃空肠吻合术(传统组)。采用SPSS 21.0统计软件包进行分析,围术期各项指标以(±s)表示,采用独立样本t检验;术后并发症比较采用χ2检验;患者术后满意度比较采用U检验。P<0.05为差异有统计学意义。

结果

两组患者手术平均时间、失血量、术后通气时间,进食时间、住院时间及患者术后1个月白蛋白增加等指标,差异无统计学意义(P均>0.05)。传统组有6例(16.7%)发生了胃排空障碍,而改良组未发生胃排空障碍,差异有统计学意义(P=0.032);改良组术后总并发症发生率4.0%明显低于传统组22.2%,差异有统计学意义(P=0.048);改良组患者术后满意度明显高于传统组,差异有统计学意义(P=0.016)。

结论

改良Devine术可明显缓解症状,术后并发症低,患者满意度高是一种安全有效的手术方式,值得推广应用。

Objective

To investigate the safety and feasibility of two different surgical methods for patients with unresectable distal gastric cancer.

Methods

Clinical data of 61 patients with unresectable distal gastric cancer who underwent surgical treatment from September 2012 to September 2019 were analyzed retrospectively. Among them, 25 cases underwent modified Devine operation (modified group), and 36 cases underwent traditional gastrojejunostomy (traditional group). Statistical analysis were performed by using SPSS21.0 software package. The perioperative indicators were expressed as (±s) and were analyzed by using independent sample t-test. The postoperative complications were compared by using χ2 test. The postoperative satisfaction of patients were compared by using Mann-Whitney U test. A P value of <0.05 was considered as statistically significant difference.

Results

There were no significant difference between two groups, in terms of the average operation time, blood loss, postoperative ventilation time, eating time, hospitalization time and ALB increase at 1 month after operation (P>0.05). There were 6 cases (16.7%) of gastric emptying disorder in the traditional group, while no gastric emptying disorder occurred in the modified group, with statistically significant difference (P=0.032). The total postoperative complication rate of 4.0% in the improved group was significantly lower than 22.2% in the traditional group, with statistically significant difference (P=0.048). The postoperative satisfaction of patients in improved group was signifcantly high than that in traditional group, with statistically significant difference (P=0.016).

Conclusion

Modified Devine operation could significantly relieve the symptoms and reduce the postoperative complications and improve satisfaction. It is a safe and effective surgical method, which is worthy of promotion and application.

表1 61例晚期不可切除远端胃癌不同术式两组患者的基线资料对比[(±s),例]
图1 改良Devine术示意图
图2 胃空肠吻合术示意图
表2 61例晚期不可切除远端胃癌不同术式两组患者围术期指标对比[(±s),例]
表3 61例晚期不可切除远端胃癌不同术式两组患者的并发症资料对比[例(%)]
表4 61例晚期不可切除远端胃癌患者不同术式患者及家属满意度调查[例(%)]
[1]
Tan ZY. Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review[J]. Med Sci Monit, 2019, 25, 3537-3541.
[2]
Kwon SJ. Bypass Surgery in Unresectable Distal Gastric Cancer[J]. J Korean Surg Soc, 1999, 57(Suppl): 984-989.
[3]
日本胃癌學會. 胃癌治療ガイドライン[M]. 5版. 東京:金原出版株式会社,2018.
[4]
Kaminishi M, Yamaguchi H, Shimizu N, et al.Stomach-partitioning gastrojejunostomy for unresectable gastriccarcinoma[J]. Arch Surg, 1997, 132(2): 184-187.
[5]
Ojima T, Nakamori M, Nakamura M, et al. Laparoscopic Gastrojejunostomy for Patients with Unresectable Gastric Cancer with Gastric Outlet Obstruction[J]. J Gastrointest Surg, 2017, 21(8): 1220-1225.
[6]
Shinde A, Novak J, Amini A, et al. The evolving role of Laparoscopic therapy for resectable and unresectable gastric cancer[J]. Transl Gastroenterol Hepatol, 2019, 4: 64.
[7]
刘昊,徐泉,马福海,等. 全腹腔镜胃部分离断后胃肠吻合术治疗胃癌合并幽门梗阻的临床效果[J].中华肿瘤杂志,2020,42(6):445-448.
[8]
魏波,卫洪波.进展期胃癌的外科治疗策略[J]. 中华胃肠外科杂志,2018,21(10):1099-1102.
[9]
Wang TB, Wang NC, Ren H, et al. Long-term Results of Conversion Therapy for Initially Unresectable Gastric Cancer: Analysis of 122 Patients at the National Cancer Center in China[J]. J Cancer, 2019, 10(24): 5975-5985.
[10]
崔航天,罗天航.不可切除胃癌转化治疗的研究进展[J]. 上海医学,2017.40(12):771-774.
[11]
Lopez-Sanchez J, Martin AF, Fernandez O A-L, et al. Stomach-partitioning Gastrojejunostomy Versus Stent Placement for the Treatment of Malignant Gastric Outlet Obstruction[J]. Cir Esp, 2019, 97(7): 385-390.
[12]
Kwok SP, Chung SC, Griffin SM, et al. Devine exclusion for unresectable carcinoma of the stomach[J]. Br J Surg, 1991, 78(6): 684-685.
[13]
Mamos MFKP, Barchi LC, de Oliveira RJ, et al. Gastric partitioning for the treatment of malignant gastric outlet obstruction[J]. World J Gastrointest Oncol, 2019, 11(12): 1161-1171.
[14]
Fernandez-Moreno MC, Marti-Obiol R, Lopez F, et al. Modified Devine Exclusion for Unresectable Distal Gastric Cancer in Symptomatic Patients[J]. Case Rep Gastroenterol, 2017, 11(1): 9-16.
[15]
Ojima T, Nakamori M, Nakamura M, et al. Laparoscopic Gastrojejunostomy for Patients with Unresectable Gastric Cancer with Gastric Outlet Obstruction[J]. J Gastrointest Surg, 2017, 21(8): 1220-1225.
[16]
Min S-H, Son S-Y, Jung D-H, et al. Laparoscopic stomach partitioning-gastrojejunostomy versus duodenal stenting in unreseetable gastric cancer with gastric outlet obstruction[J]. Ann Surg Treat Res, 2017, 93(3): 130-136.
[17]
王静铭,邢俊杰,刘宏,等. 3D腹腔镜与2D腹腔镜辅助远端胃癌D2根治术的应用对比[J/CD]. 中华普外科手术学杂志(电子版),2018,12(2):115-118.
[1] 安杰, 牛云峰, 刘伟. LINC00520 通过miR-519b-3p/HIF1A 轴促进胃癌的侵袭转移[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 430-436.
[2] 许革新, 何琦, 毛智军, 普彦淞, 杨淦傑, 王建华. 我国胃肿瘤外科治疗现状及发展趋势—基于CiteSpace的可视化分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 350-356.
[3] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[4] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[5] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[6] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[7] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[8] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[9] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[10] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[11] 贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[12] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[13] 刘海旺, 施海, 尚利峰. 不同吻合器在腹腔镜远端胃癌根治术Roux-en-Y式吻合中的应用对比[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 643-646.
[14] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[15] 张立俊, 孙存杰, 胡春峰, 孟冲, 张辉. MSCT、DCE-MRI 评估术前胃癌TNM 分期的准确性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 519-523.
阅读次数
全文


摘要